基于专利分析的江苏生物医药发展现状与对策研究

doi:10.13523/j.cb.20160816

中国生物工程杂志

2016, Vol. 36

Issue (8): 123-130 DOI: 10.13523/j.cb.20160816

医药生物技术专栏

基于专利分析的江苏生物医药发展现状与对策研究

夏太寿^1,2, 王园磊¹, 田丽丽¹

1. 江苏大学科技信息研究所镇江 2120131;
2. 江苏省生产力促进中心南京 210042

Reserch on Present Situation and Countermeasure of Jiangsu Biomedical Business Based on Patent

XIA Tai-shou^1,2, WANG Yuan-lei¹, TIAN Li-li¹

1. Institute of Science and Technology Information, Jiangsu University, Zhenjiang 212013, China;
2. Productivity Promotion Center of Jiangsu Province, Nanjing 210042, China

全文: PDF(655 KB) HTML

摘要：

以国家知识产权数据库为统计源，对1995～2014年间的生物医药技术研究的专利文献进行统计分析，给出江苏生物医药专利的总体发展态势、地区分布、IPC技术构成和专利高产机构，同时基于技术领域的专利组合，与国内代表性省市北京、山东、上海以及美国进行对比分析，最后重点分析了江苏生物医药企业专利申请情况及地区分布，为江苏及各省制定更加合理的技术发展对策提供专利视角的参考。

关键词： 生物医药; 专利分析; 江苏; 发展对策

Abstract:

Taking the database of national intellectual property as the statistic source, the statistics of the patent document about biomedical technological study were analysed, that offering the general development trend of biomedical patent in Jiangsu, its regional distribution, IPC technical composition and prolific institutions of patent. Meanwhile, based on the patent portfolio in the technical field, comparative analysis has been made with representative regions and provinces in China like Beijing, Shandong and Shanghai as well as the USA. Finally, the focus is on the application and regional distribution of biomedical enterprises in Jiangsu, that provides Jiangsu and other provinces with patent references for working out more appropriate strategies in terms of technological development.

Key words: Biomedicine Jiangsu Patent analysis Development countermeasure

收稿日期: 2016-02-26 出版日期: 2016-03-16

ZTFLH:

F203

通讯作者: 王园磊 E-mail: 942879129@qq.com

	服务
	把本文推荐给朋友
	加入引用管理器
	E-mail Alert
	RSS
	作者相关文章
	夏太寿
	王园磊
	田丽丽

引用本文:

夏太寿, 王园磊, 田丽丽. 基于专利分析的江苏生物医药发展现状与对策研究[J]. 中国生物工程杂志, 2016, 36(8): 123-130.

XIA Tai-shou, WANG Yuan-lei, TIAN Li-li. Reserch on Present Situation and Countermeasure of Jiangsu Biomedical Business Based on Patent. China Biotechnology, 2016, 36(8): 123-130.

链接本文:

https://manu60.magtech.com.cn/biotech/CN/10.13523/j.cb.20160816 或 https://manu60.magtech.com.cn/biotech/CN/Y2016/V36/I8/123

[1] 王健聪.生物医药产业发展规律与政策研究——基于产业经济的视角.湖北:华中师范大学,2014. Wang J C.A Study of the rule and policy of biopharmaceutical industry development——from the perspective of industrial economy. Hubei:Central China Normal University,2014.
[2] 于洁,肖宏,于建荣.生物能源领域国际相关专利分析.中国生物工程杂志,2007,27(7):137-141. Yu J,Xiao H,Yu J R. Study on international patents of bioenergy technologies.China Biotechnology,2007,27(7):137-141.
[3] Day G S,Schoemaker P J,Gunther R E. Wharton on Managing Emerging Technologies. New York:John Wiley & Sons,Inc.,2000.245-247.
[4] 余景亮,孙峰,曹曼.江苏生物技术和新医药产业发展现状及对策研究.特区经济,2015,1:42-43. Yu J L,Sun F,Cao M.Jiangsu biotechnology and new medicine industry development present situation and countermeasure research.Special Zone Economy,2015,1:42-43.
[5] 李洁.基于产业集聚的江苏生物医药产业布局模式研究.科技管理研究,2015,32(12):167-172. Li J. Researches of bio-pharmaceutical industry location pattern under the background of industrial agglomeration in Jiangsu province.Science and Technology Management Research,2015,32(12):167-172.
[6] 韩子睿,张雯,李子萤.苏州生物医药产业的发展现状及对策建议.江苏科技信息,2015,23:14-19. Han Z R,Zhang W,Li Z Y. Development status and suggestions on biological medicine industry in suzhou. Jiangsu Science & Technology Information,2015,23:14-19.
[7] 胡勇.生物医药产业转型发展研究——以无锡市为例.江南论坛,2014,9:39-40. Hu Y. Biological medicine industry transformation development research——in wuxi city as an example. Jiangnan Forum,2014,9:39-40.
[8] 刘玉委,唐正康.连云港发展海洋生物医药新兴产业的可行性研究.当代经济,2014,19:88-89. Liu Y W,Tang Z K. Feasibility study of Lianyungang marine biological pharmaceutical industry development. Contemporary Economics,2014,19:88-89.
[9] 郭柯磊,欧阳昭连,杜然然,等.国际生物技术专利计量分析.生物技术通讯,2011,22(2):248-251. Guo K L,Ouya Z L,Du R R,et al. Study of international patents on biotechnology. Letters in Biotechnology,2011,22(2):248-251.
[10] Ernst H. Patent portfolios for strategic R&D planning.Journal of Engineering and Technology Management,1998,15(4):279-308.
[11] Ernst H. The patent asset index:a new approach to benchmark patent portfolios.World Patent Inform,2001,33(1):34-41.
[12] 李建成.我国高校科技成果转化的对策和现状研究.长沙:湖南大学,2008. Li J C.An analysis on the present situation and strategies of transformation of scientific research achievement in chinese universities and colleges.Changsha:Hunan University,2008.
[13] 冯晓青.我国企业专利申请存在问题、成因及对策研究——从企业专利申请与经济实力的关系论起.北京工业大学学报,2008,8(6):62-67. Feng X Q. Research on the problems and their causes and countermeasure of patent application of China's enterprises:starting from the relationship of patent application of enterprises and their economic strength.Journal of Beijing University of Technology,2008,8(6):62-67.

[1]	谭清立,林岱衡,刘珈瑗,林兴纯. 基于灰色综合关联分析法的粤港澳大湾区生物医药产业效益研究^*[J]. 中国生物工程杂志, 2021, 41(6): 89-97.
[2]	陈莹,李谦. 特殊酵母工业应用专利发展态势分析[J]. 中国生物工程杂志, 2021, 41(4): 91-99.
[3]	尹政清,白京羽,林晓锋. 美国生物医药产业竞争力分析与启示[J]. 中国生物工程杂志, 2020, 40(9): 87-94.
[4]	白京羽,林晓锋,尹政清. 基于文献计量的全球生物技术研究现状与发展趋势分析[J]. 中国生物工程杂志, 2020, 40(7): 100-109.
[5]	蒋甜,张超,刘会洲. 微生物燃料电池发展态势分析[J]. 中国生物工程杂志, 2020, 40(1-2): 189-197.
[6]	谢华玲,吕璐成,杨艳萍. 全球冠状病毒疫苗专利分析[J]. 中国生物工程杂志, 2020, 40(1-2): 57-64.
[7]	黄鹏飞,陈赟,陆娇,毛开云,袁银池. *生物医药专利密集型产业发展现状及建议^——以上海市为例**[J]. 中国生物工程杂志, 2020, 40(12): 108-116.
[8]	胡鸢雷,姚卫浩,濮润,张宏翔. 美国创新创业生态系统中生物技术孵化器的作用[J]. 中国生物工程杂志, 2019, 39(12): 103-109.
[9]	毕晴,孙琳. CAR-T技术中外专利申请分析与比较[J]. 中国生物工程杂志, 2018, 38(4): 107-114.
[10]	李东巧, 郭文姣, 陈芳. 基于专利分析的转基因药用植物技术发展趋势研究[J]. 中国生物工程杂志, 2016, 36(11): 98-108.
[11]	赵绘存. 基于专利信息可视化的生物反应器发展态势分析[J]. 中国生物工程杂志, 2016, 36(1): 115-121.
[12]	濮润, 李萍萍, 苏月, 朱敏, 华玉涛. 我国生物医药园区发展特点及未来发展建议[J]. 中国生物工程杂志, 2015, 35(3): 104-106.
[13]	吴学彦, 韩雪冰, 戴磊. 基于DII的转基因大豆领域专利计量分析[J]. 中国生物工程杂志, 2013, 33(3): 143-148.
[14]	梅建国, 庄金秋, 王金良, 王玉茂, 丁壮, 沈志强. 动物细胞大规模培养技术[J]. 中国生物工程杂志, 2012, 32(07): 127-132.
[15]	赵冰, 张东生, 赵拥政. 区域生物医药产业基于钻石模型的竞争力研究——以石家庄为例[J]. 中国生物工程杂志, 2011, 31(9): 140-145.

Viewed

Full text

Abstract

Cited

Shared

Discussed